Ziegler Announced as Finalist for Three 16th Annual M&A Advisor Awards

Ziegler, a specialty investment bank, is pleased to announce that it has been nominated for three M&A Advisor awards:

  • Radiology Alliance in its acquisition by MEDNAX, which Ziegler served as the sole financial advisor, has been named a finalist for Healthcare and Life Sciences Deal of the Year and Corporate/Strategic Deal of the Year categories.
  • Med Fusion in its recent sale to Quest Diagnostics, which Ziegler served as the sole financial advisor, has been named a finalist in the >$100mm category for the Healthcare and Life Sciences Deal of the Year and the M&A Deal of the Year awards.
  • Oncology Hematology Care (OHC) in its recent partnership with The US Oncology Network (the Network), which Ziegler served as the sole financial advisor, has been named a finalist in the Corporate/Strategic Deal of the Year category.

Ziegler served as the exclusive financial advisor to Radiology Alliance, P.C., and Infinity Management, LLC, on their acquisition by MEDNAX. Andrew Colbert, Managing Director in Ziegler’s Corporate Finance practice stated, “This acquisition was an important strategic move for Radiology Alliance as it aligns them with one of the nation’s largest multispecialty physician groups in the United States.” He continued, “By acquiring Radiology Alliance, MEDNAX is moving into the onsite radiology marketplace by partnering with one of the premier radiology groups in the country. I expect that radiology will a major growth initiative for MEDNAX in the future.”

Grant Chamberlain, Managing Director in Ziegler’s Corporate Finance Healthcare practice, commented on the MedFusion transaction, “This transaction was emblematic of the way we at Ziegler help our clients achieve their goals in an increasingly complex healthcare environment. I believe the entity and partnerships we have built between Quest and the original founders will help improve the care of cancer patients.” The transaction allowed Quest Diagnostics to acquire Med Fusion, creating a base in the southwestern United States for providing precision medicine diagnostics to aid cancer treatment and care.

Regarding the Oncology Hematology Care transaction, Mr. Chamberlain, added, “Having spent over 20 years advising physician practices in over 25…

Read the full article from the Source…

Leave a Reply

Your email address will not be published. Required fields are marked *